Understanding Farydak® (panobinostat) capsules

Farydak is the first histone deacetylase (HDAC) inhibitor approved for use in treating myeloma. Farydak is taken in capsule form in combination with Velcade® (bortezomib) and dexamethasone. by patients who have already been treated with Vel¬cade and an immunomodulatory drug.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.